Skip to main content
. 2021 Mar 30;204(11):1259–1273. doi: 10.1164/rccm.202010-3754OC

Table 2.

Correlations between ILC2 : ILC1 Ratios, IL-33, and Type 2 Soluble Mediator Levels in Nasal Mucosal Lining Fluid during Rhinovirus Infection

Baseline ILC2:ILC1 Ratio
IL-33  
 Day 0 r = 0.489, P = 0.018
IL-5  
 Day 0 r = 0.557, P = 0.006
 Day 2 r = 0.415, P = 0.049
 Day 3 r = 0.356, P = 0.096
 Day 4 r = 0.430, P = 0.041
 Day 5 r = 0.545, P = 0.007
 Day 6 r = 0.538, P = 0.008
 Day 11 r = 0.561, P = 0.008
 Day 15 r = 0.474, P = 0.026
IL-13  
 Day 5 r = 0.433, P = 0.039
IL-4  
 Day 6 r = 0.543, P = 0.008
IL-9  
 Day 4
r = 0.420, P = 0.046
Day 3 ILC2:ILC1 Ratio
IL-5  
 Day 3 r = 0.446, P = 0.038
 Day 4 r = 0.589, P = 0.004
IL-13  
 Day 4 r = 0.532, P = 0.011
 Day 8 r = 0.500, P = 0.018
IL-4  
 Day 6 r = 0.544, P = 0.009
 Day 8 r = 0.461, P = 0.031
IL-9  
 Day 3 r = 0.634, P = 0.002
 Day 4 r = 0.379, P = 0.082
MDC  
 Day 1 r = 0.470, P = 0.027
TARC  
 Day 1 r = 0.478, P = 0.025
 Day 2
r = −0.499, P = 0.018
Day 8 ILC2:ILC1 Ratio
IL-5  
 Day 11 r = 0.635, P = 0.002
IL-13  
 Day 11 r = 0.544, P = 0.089
MDC  
 Day 5 r = 0.420, P = 0.046
 Day 6 r = 0.463 P = 0.026
TARC  
 Day 6 r = 0.478, P = 0.021

Definition of abbreviations: ILC = innate lymphoid cell; MDC = macrophage-derived chemokine; TARC = thymus and activation-regulated chemokine.

Boldface text indicates significant P values.